Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Family Law Quarterly
|
July 1, 1997
Should parents be permitted to authorize genetic testing for their children?
Julie Holland
Nursing Economic$
|
March 20, 2013
Evidence-based leadership
Julie Holland
Psychopharmacology
|
November 21, 2017
Progress and promise for the MDMA drug development program
Allison A Feduccia, Julie Holland, Michael C Mithoefer
Frontiers in Neurology
|
August 16, 2021
Psychedelics for Brain Injury: A Mini-Review
Mia Khan, Gregory T Carter, Sunil K Aggarwal, et al.
Psychopharmacology
|
August 10, 2024
Retraction Note: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy
Allison A Feduccia, Lisa Jerome, Michael C Mithoefer, et al.
Psychopharmacology
|
November 22, 2020
Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy
Allison A Feduccia, Lisa Jerome, Michael C Mithoefer, et al.
The Journal of Applied Psychology
|
July 15, 2009
An experience sampling study of learning, affect, and the demands control support model
Kevin Daniels, Grahame Boocock, Jane Glover, et al.
Human Psychopharmacology
|
March 5, 2014
A reconsideration and response to Parrott AC (2013) "Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research"
Rick Doblin, George Greer, Julie Holland, et al.
Biological Psychiatry
|
December 28, 2017
Response to the Consensus Statement of the PTSD Psychopharmacology Working Group
Allison A Feduccia, Michael C Mithoefer, Lisa Jerome, et al.
Journal of Clinical Medicine
|
June 24, 2022
MDMA for the Treatment of Negative Symptoms in Schizophrenia
Mitchell D Arnovitz, Andrew J Spitzberg, Ashkhan J Davani, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Family Law Quarterly
|
July 1, 1997
Should parents be permitted to authorize genetic testing for their children?
Julie Holland
Nursing Economic$
|
March 20, 2013
Evidence-based leadership
Julie Holland
Psychopharmacology
|
November 21, 2017
Progress and promise for the MDMA drug development program
Allison A Feduccia, Julie Holland, Michael C Mithoefer
Frontiers in Neurology
|
August 16, 2021
Psychedelics for Brain Injury: A Mini-Review
Mia Khan, Gregory T Carter, Sunil K Aggarwal, et al.
Psychopharmacology
|
August 10, 2024
Retraction Note: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy
Allison A Feduccia, Lisa Jerome, Michael C Mithoefer, et al.
Psychopharmacology
|
November 22, 2020
Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy
Allison A Feduccia, Lisa Jerome, Michael C Mithoefer, et al.
The Journal of Applied Psychology
|
July 15, 2009
An experience sampling study of learning, affect, and the demands control support model
Kevin Daniels, Grahame Boocock, Jane Glover, et al.
Human Psychopharmacology
|
March 5, 2014
A reconsideration and response to Parrott AC (2013) "Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research"
Rick Doblin, George Greer, Julie Holland, et al.
Biological Psychiatry
|
December 28, 2017
Response to the Consensus Statement of the PTSD Psychopharmacology Working Group
Allison A Feduccia, Michael C Mithoefer, Lisa Jerome, et al.
Journal of Clinical Medicine
|
June 24, 2022
MDMA for the Treatment of Negative Symptoms in Schizophrenia
Mitchell D Arnovitz, Andrew J Spitzberg, Ashkhan J Davani, et al.
Page
of 2